Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain

NCT07682662 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT07682662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07682662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain
Lead sponsor
University of Mississippi Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
October 1, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease (scd), vaso-occlusive pain episode in sickle cell disease